You have 9 free searches left this month | for more free features.

untreated;

Showing 26 - 50 of 7,098

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

Recruiting
  • Follicular Lymphoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

LOng-Term Fate of Moderate Aortic Regurgitation Left Untreated

Completed
  • Aortic Regurgitation
  • Mitral Regurgitation
  • Mitral valve surgery
  • Aortic valve surgery
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Mar 16, 2023

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • (no location specified)
Jun 14, 2023

Untreated Mantle Cell Lymphoma Trial in Suzhou (zanubrutinib and rituximab, BEAM pretreatment, zanubrutinib maintenance)

Recruiting
  • Untreated Mantle Cell Lymphoma
  • zanubrutinib and rituximab
  • +2 more
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Aug 16, 2022

Previously Untreated Peripheral T-cell Lymphoma Trial in Tampa, Saint Louis, New York (CC-486 Administration, CHOP

Active, not recruiting
  • Previously Untreated Peripheral T-cell Lymphoma
  • CC-486 Administration
  • CHOP Administration
  • Tampa, Florida
  • +3 more
Jan 18, 2023

Cervical Intraepithelial Neoplasia Grade 2, DNA Methylation Trial in Maribor (Testing DNA methylation test for predicting

Recruiting
  • Cervical Intraepithelial Neoplasia Grade 2
  • DNA Methylation
  • Testing DNA methylation test for predicting prognosis of untreated CIN 2
  • Maribor, Slovenia
    University Medical Centre Maribor
Nov 14, 2022

Bacterial Vaginosis Trial in Sweden (pHyph)

Not yet recruiting
  • Bacterial Vaginosis
  • pHyph
  • Linköping, Sweden
  • +3 more
Nov 7, 2023

Urothelial Carcinoma Trial (disitamab vedotin, pembrolizumab, gemcitabine)

Not yet recruiting
  • Urothelial Carcinoma
  • disitamab vedotin
  • +4 more
  • (no location specified)
Jun 9, 2023

Breast Cancer Trial (RO7247669, Pembrolizumab, Nab-Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
May 2, 2023

NSCLC Stage IV Trial in New York (Pembrolizumab, Radiation, Chemotherapy)

Recruiting
  • NSCLC Stage IV
  • New York, New York
    NYU Langone Health
Jan 11, 2023

Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

Not yet recruiting
  • Large B-Cell Lymphoma
  • Xi'an, China
    First Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023

Tumors, Rectal Trial (Dostarlimab)

Not yet recruiting
  • Neoplasms, Rectal
  • Dostarlimab
  • (no location specified)
Feb 2, 2023

Untreated Myelodysplastic Syndrome Trial in France (Onureg + Venetoclax)

Not yet recruiting
  • Untreated Myelodysplastic Syndrome
  • Onureg + Venetoclax
  • Angers, France
  • +9 more
Mar 13, 2023

Fate at Long-term of Mild to Moderate Bicuspid Aortic Valve

Completed
  • Bicuspid Aortic Valve
  • Ascending Aorta Aneurysm
  • Ascending aorta replacement
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Apr 28, 2023

Schizophrenia, First Episode Psychosis Trial in Glen Oaks, Queens (search engine advertisement campaign)

Active, not recruiting
  • Schizophrenia
  • First Episode Psychosis
  • search engine advertisement campaign
  • Glen Oaks, New York
  • +1 more
Sep 27, 2022

Non Small Cell Lung Cancer, Brain Metastases Trial (Cadonilimab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Brain Metastases
  • (no location specified)
Apr 2, 2023

Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

Recruiting
  • Urothelial Cancer
  • Beijing, China
    Beijing Cancer Hospital
Jan 18, 2023

Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

Recruiting
  • Renal Cell Carcinoma
  • Beijing, China
  • +1 more
Mar 28, 2023

Advance NSCLC Trial (GFH925, Cetuximab)

Not yet recruiting
  • Advance Non-small Cell Lung Cancer
  • (no location specified)
Mar 7, 2023

Pseudotumor Cerebri, Idiopathic Intracranial Hypertension (IIH) Trial in Phoenix, Seattle (Dural Venous Sinus Stenting,

Recruiting
  • Pseudotumor Cerebri
  • Idiopathic Intracranial Hypertension (IIH)
  • Dural Venous Sinus Stenting
  • Cerebrospinal Fluid Shunting
  • Phoenix, Arizona
  • +1 more
Jan 17, 2023

Mantle Cell Lymphoma Trial in Houston (Ibrutinib)

Recruiting
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Nov 1, 2022

Waldenstrom's Macroglobulinemia Trial in Boston (Ibrutinib)

Completed
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
  • +1 more
Dec 5, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

Metastatic Melanoma, Unresectable Melanoma, Melanoma Trial (Lifileucel plus Pembrolizumab, Pembrolizumab with Optional Crossover

Not yet recruiting
  • Metastatic Melanoma
  • +2 more
  • Lifileucel plus Pembrolizumab
  • Pembrolizumab with Optional Crossover Period
  • (no location specified)
Feb 13, 2023

Lymphoma, Follicular, Follicular Lymphoma Trial in Saint Louis (Mosunetuzumab, Polatuzumab vedotin)

Recruiting
  • Lymphoma, Follicular
  • Follicular Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 14, 2022